CA Stock MarketDetailed Quotes
IPA ImmunoPrecise Antibodies Ltd
- 0.000
- 0.0000.00%
15min DelayMarket Closed Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio24.94MShares0.00052wk Low-1.06EPS TTM0Float Cap0.000Historical High0.00P/E (Static)24.94MShs Float0.000Historical Low-0.85EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
ImmunoPrecise Antibodies Ltd Key Stats
Quarterly+Annual
YOY
| (Q1)Jul 31, 2022 | (FY)Apr 30, 2022 | (Q4)Apr 30, 2022 | (Q3)Jan 31, 2022 | (Q2)Oct 31, 2021 | (Q1)Jul 31, 2021 | (FY)Apr 30, 2021 | (Q4)Apr 30, 2021 | (Q3)Jan 31, 2021 | (Q2)Oct 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -968.81%-10.31M | -1,553.50%-9.92M | -144.46%-1.79M | -618.25%-5.16M | -556.24%-2.01M | -336.52%-965K | 56.87%-600K | -257.58%-731K | -1,597.08%-718K | 128.11%441K |
| Net income from continuing operations | -190.43%-9.38M | -127.64%-16.71M | 7.73%-4.64M | -195.67%-3.83M | -979.53%-5.01M | -488.34%-3.23M | -48.37%-7.34M | -432.36%-5.03M | -106.76%-1.29M | 65.97%-464K |
| Operating gains losses | 95.80%-18K | -158.91%-562K | -77.71%275K | -775.38%-569K | 149.39%161K | -486.49%-429K | 1,390.63%954K | 1,036.19%1.23M | -194.36%-65K | -6,038.07%-326K |
| Depreciation and amortization | 61.96%1.55M | 1.51%3.77M | 3.93%926K | 1.39%949K | -3.80%937K | 4.93%957K | 8.98%3.71M | -37.84%891K | 53.99%936K | 46.78%974K |
| Asset impairment expenditure | ---- | --167K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Remuneration paid in stock | -31.99%759K | 12.19%3.08M | -40.54%786K | -42.32%492K | 44.75%689K | 1,050.52%1.12M | 271.85%2.75M | 1,280.17%1.32M | 496.09%853K | 122.31%476K |
| Deferred tax | -174.74%-261K | -304.82%-336K | -536.97%-922K | 943.00%843K | 16.49%-162K | ---95K | 81.76%-83K | 142.85%211K | -187.59%-100K | -798.19%-194K |
| Other non cashItems | -87.50%3K | -80.05%85K | -85.61%20K | -73.08%21K | -81.48%20K | -76.24%24K | -55.02%426K | 118.85%139K | -33.69%78K | -49.29%108K |
| Change In working capital | -528.61%-2.97M | 157.17%582K | 250.89%1.77M | -187.21%-3.23M | 1,116.54%1.35M | 362.12%692K | 8.94%-1.02M | 120.97%505K | -140.55%-1.13M | 89.61%-133K |
| -Change in receivables | -268.89%-380K | 652.17%254K | -90.94%57K | -147.41%-530K | 3,246.67%502K | 112.44%225K | 97.31%-46K | 182.89%629K | 285.99%1.12M | 102.08%15K |
| -Change in inventory | 127.96%26K | -58.54%-501K | -2,771.43%-201K | -6,466.67%-197K | 90.65%-10K | 53.27%-93K | -1,273.91%-316K | -105.36%-7K | 98.46%-3K | -75.40%-107K |
| -Change in prepaid assets | -124.90%-120K | 42.47%-772K | -87.57%88K | 45.00%-1.1M | -87.60%-242K | 510.13%482K | -595.34%-1.34M | 1,639.80%708K | -23,313.72%-2M | 16.04%-129K |
| -Change in payables and accrued expense | -3,765.08%-2.44M | 66.89%1.46M | 424.00%1.18M | -239.92%-340K | 579.72%686K | -111.43%-63K | 409.30%876K | -71.74%225K | 314.03%243K | 25.36%-143K |
| -Change in other working capital | -140.43%-57K | 173.16%139K | 161.81%649K | -120.45%-1.07M | 80.09%416K | -87.33%141K | -129.97%-190K | -1,086.10%-1.05M | -207.66%-484K | 251.29%231K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -968.81%-10.31M | -1,553.50%-9.92M | -144.46%-1.79M | -618.25%-5.16M | -556.24%-2.01M | -336.52%-965K | 56.87%-600K | -257.58%-731K | -1,597.08%-718K | 128.11%441K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 73.82%-89K | -112.05%-5.21M | -400.98%-4.09M | -78.02%-664K | 84.48%-111K | 38.29%-340K | -55.15%-2.46M | -2,066.76%-817K | 70.94%-373K | -296.46%-715K |
| Net PPE purchase and sale | 73.82%-89K | 25.30%-1.07M | 75.39%-142K | -23.82%-473K | 75.71%-111K | -2,990.91%-340K | -208.87%-1.43M | -514.77%-577K | -114.49%-382K | -283.55%-457K |
| Net intangibles purchas and sale | ---- | ---191K | -170.74%-191K | ---- | ---- | ---- | --0 | 384.60%270K | 109.19%9K | -321.60%-258K |
| Net business purchase and sale | ---- | -258.79%-3.69M | -623.92%-3.69M | ---- | ---- | ---- | -2.18%-1.03M | -117,341.38%-510K | --0 | --0 |
| Net other investing changes | ---- | ---259K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 73.82%-89K | -112.05%-5.21M | -400.98%-4.09M | -78.02%-664K | 84.48%-111K | 38.29%-340K | -55.15%-2.46M | -2,066.76%-817K | 70.94%-373K | -296.46%-715K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 27.62%-152K | -93.35%2.88M | -89.35%3.06M | -153.68%-51K | -99.25%82K | -105.88%-210K | 24,830.46%43.38M | 4,868.57%28.75M | 316.80%95K | 4,455.70%10.97M |
| Net issuance payments of debt | -14.83%-271K | -24.61%-962K | -4.42%-260K | -74.26%-237K | 25.16%-229K | -191.36%-236K | -142.01%-772K | -343.93%-249K | -210.37%-136K | -21.53%-306K |
| Net common stock issuance | 357.69%119K | -91.28%3.85M | -88.53%3.33M | -19.48%186K | -97.24%311K | -99.29%26K | 8,855.58%44.15M | 5,985.20%29M | --231K | 751,433.33%11.27M |
| Net other financing activities | ---- | ---5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 27.62%-152K | -93.35%2.88M | -89.35%3.06M | -153.68%-51K | -99.25%82K | -105.88%-210K | 24,830.46%43.38M | 4,868.57%28.75M | 316.80%95K | 4,455.70%10.97M |
| Net cash flow | ||||||||||
| Beginning cash position | -28.18%30.05M | 1,454.74%41.84M | 109.27%33.07M | 127.11%38.44M | 563.41%40.78M | 1,454.74%41.84M | -51.42%2.69M | 688.24%15.8M | 465.94%16.93M | 23.22%6.15M |
| Current changes in cash | -596.70%-10.56M | -130.37%-12.25M | -110.36%-2.82M | -489.56%-5.87M | -119.09%-2.04M | -144.21%-1.52M | 1,540.11%40.32M | 2,606.99%27.2M | 27.28%-996K | 634.33%10.69M |
| Effect of exchange rate changes | -136.76%-168K | 138.69%455K | 82.62%-202K | 490.63%500K | -452.94%-300K | 1,475.86%457K | -2,350.00%-1.18M | -265.11%-1.16M | -133.37%-128K | 2,704.35%85K |
| End cash Position | -52.61%19.32M | -28.18%30.05M | -28.18%30.05M | 109.27%33.07M | 127.11%38.44M | 563.41%40.78M | 1,454.74%41.84M | 1,454.74%41.84M | 688.24%15.8M | 465.94%16.93M |
| Free cash from | -697.16%-10.4M | -451.46%-11.18M | -104.24%-2.12M | -416.04%-5.63M | -674.82%-2.12M | -447.07%-1.31M | -3.05%-2.03M | -343.80%-1.04M | -242.75%-1.09M | 84.34%-274K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data